Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of coronary artery tortuosity on outcomes following stenting with newer-generation drug-eluting stents. An analysis of the randomized BIOFLOW trials.
Mankerious N, Toelg R, Abdelghani M, Garcia-Garcia HM, Farhan S, Allali A, Windecker S, Lefèvre T, Saito S, Kandzari DE, Waksman R, Richardt G, Hemetsberger R. Mankerious N, et al. Among authors: abdelghani m. Rev Esp Cardiol (Engl Ed). 2025 Jan 4:S1885-5857(24)00370-0. doi: 10.1016/j.rec.2024.12.009. Online ahead of print. Rev Esp Cardiol (Engl Ed). 2025. PMID: 39761745 Free article. English, Spanish.
Organ-specific response to [177Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [68Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumors.
Mamulashvili Bessac D, Baltzinger P, Poterszman N, Pham Van F, Collen C, Malouf GG, Ouvrard E, Kaseb A, Porot C, Ben Abdelghani M, Addeo P, Mertz L, Goichot B, Imperiale A. Mamulashvili Bessac D, et al. Among authors: ben abdelghani m. Endocrine. 2024 Dec 23. doi: 10.1007/s12020-024-04138-y. Online ahead of print. Endocrine. 2024. PMID: 39714577
Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer.
Andre T, Elez E, Van Cutsem E, Jensen LH, Bennouna J, Mendez G, Schenker M, de la Fouchardiere C, Limon ML, Yoshino T, Li J, Lenz HJ, Manzano Mozo JL, Tortora G, Garcia-Carbonero R, Dahan L, Chalabi M, Joshi R, Goekkurt E, Braghiroli MI, Cil T, Cela E, Chen T, Lei M, Dixon M, Abdullaev S, Lonardi S; CheckMate 8HW Investigators. Andre T, et al. N Engl J Med. 2024 Nov 28;391(21):2014-2026. doi: 10.1056/NEJMoa2402141. N Engl J Med. 2024. PMID: 39602630 Clinical Trial.
Early palliative care and overall survival in patients with metastatic upper gastrointestinal cancers (EPIC): a multicentre, open-label, randomised controlled phase 3 trial.
Adenis A, Da Silva A, Ben Abdelghani M, Bourgeois V, Bogart E, Turpin A, Evin A, Proux A, Galais MP, Jaraudias C, Quintin J, Bouquet G, Samalin E, Bremaud N, Javed S, Henry A, Kurtz JE, Cornuault-Foubert D, Vandamme H, Lucchi E, Pannier D, Belletier C, Paul M, Touzet L, Penel N, Chvetzoff G, Le Deley MC. Adenis A, et al. Among authors: ben abdelghani m. EClinicalMedicine. 2024 Jun 28;74:102470. doi: 10.1016/j.eclinm.2024.102470. eCollection 2024 Aug. EClinicalMedicine. 2024. PMID: 39526177 Free PMC article.
Acceptability, tolerability and safety of the BRIGhTMIND trial: Connectivity-guided intermittent theta-burst stimulation versus F3- repetitive transcranial magnetic stimulation for treatment-resistant depression.
Webster L, Boutry C, Thomson L, Abdelghani M, Barber S, Briley PM, Kurkar M, Lankappa S, McAllister-Williams RH, Di Paola AS, Morriss R; BRIGhTMIND study and LEAP team. Webster L, et al. Among authors: abdelghani m. Compr Psychiatry. 2025 Jan;136:152544. doi: 10.1016/j.comppsych.2024.152544. Epub 2024 Nov 4. Compr Psychiatry. 2025. PMID: 39504645 Free article. Clinical Trial.
Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study.
M'Baloula J, Tougeron D, Boilève A, Jeanbert E, Guimbaud R, Ben Abdelghani M, Durand A, Turpin A, Quesada S, Blanc JF, Artru P, Toullec C, Trouilloud I, Pellat A, Touchefeu Y, Pinot J, Caroli-Bosc FX, Taïeb J, Doat S, Bouché O, Védie AL, de Mestier L, Muller M. M'Baloula J, et al. Among authors: ben abdelghani m. Eur J Cancer. 2024 Nov;212:115051. doi: 10.1016/j.ejca.2024.115051. Epub 2024 Oct 1. Eur J Cancer. 2024. PMID: 39366210 Free article.
Rationale and Design of the COPERNIC Trial: A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients.
Assaf I, Bregni G, Anthoine G, Aparicio T, Artru P, Abdelghani MB, Buyse M, Chibaudel B, Coart E, Diaz M, Evrard C, Geboes K, Ghiringhelli F, Puleo F, Raimbourg J, Vandamme T, Van den Eynde M, Hendlisz A, Sclafani F. Assaf I, et al. Among authors: abdelghani mb. Clin Colorectal Cancer. 2024 Sep 3:S1533-0028(24)00081-1. doi: 10.1016/j.clcc.2024.08.004. Online ahead of print. Clin Colorectal Cancer. 2024. PMID: 39341700
234 results